GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lisata Therapeutics Inc (LTS:0HS8) » Definitions » Cyclically Adjusted Book per Share

Lisata Therapeutics (LTS:0HS8) Cyclically Adjusted Book per Share : $58.50 (As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Lisata Therapeutics Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Lisata Therapeutics's adjusted book value per share for the three months ended in Sep. 2024 was $4.049. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $58.50 for the trailing ten years ended in Sep. 2024.

During the past 12 months, Lisata Therapeutics's average Cyclically Adjusted Book Growth Rate was -39.40% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -32.30% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -29.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Lisata Therapeutics was 51.50% per year. The lowest was -33.80% per year. And the median was -12.10% per year.

As of today (2024-12-15), Lisata Therapeutics's current stock price is $2.72. Lisata Therapeutics's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2024 was $58.50. Lisata Therapeutics's Cyclically Adjusted PB Ratio of today is 0.05.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Lisata Therapeutics was 1.93. The lowest was 0.01. And the median was 0.07.


Lisata Therapeutics Cyclically Adjusted Book per Share Historical Data

The historical data trend for Lisata Therapeutics's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lisata Therapeutics Cyclically Adjusted Book per Share Chart

Lisata Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 484.89 463.38 175.45 114.83 91.51

Lisata Therapeutics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 94.62 91.51 83.42 64.40 58.50

Competitive Comparison of Lisata Therapeutics's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, Lisata Therapeutics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lisata Therapeutics's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lisata Therapeutics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Lisata Therapeutics's Cyclically Adjusted PB Ratio falls into.



Lisata Therapeutics Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Lisata Therapeutics's adjusted Book Value per Share data for the three months ended in Sep. 2024 was:

Adj_Book= Book Value per Share /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=4.049/133.0289*133.0289
=4.049

Current CPI (Sep. 2024) = 133.0289.

Lisata Therapeutics Quarterly Data

Book Value per Share CPI Adj_Book
201412 238.622 99.070 320.417
201503 191.774 99.621 256.085
201506 179.561 100.684 237.246
201509 149.816 100.392 198.521
201512 62.699 99.792 83.581
201603 34.661 100.470 45.893
201606 15.312 101.688 20.031
201609 19.701 101.861 25.729
201612 8.940 101.863 11.675
201703 -1.325 102.862 -1.714
201706 91.592 103.349 117.895
201709 84.862 104.136 108.408
201712 79.883 104.011 102.169
201803 71.420 105.290 90.236
201806 67.471 106.317 84.423
201809 62.613 106.507 78.205
201812 57.359 105.998 71.986
201903 50.121 107.251 62.168
201906 43.103 108.070 53.058
201909 36.377 108.329 44.671
201912 29.656 108.420 36.387
202003 24.312 108.902 29.698
202006 32.542 108.767 39.801
202009 29.187 109.815 35.357
202012 25.154 109.897 30.449
202103 27.799 111.754 33.091
202106 26.446 114.631 30.690
202109 24.758 115.734 28.458
202112 23.145 117.630 26.175
202203 21.929 121.301 24.049
202206 20.399 125.017 21.706
202209 9.160 125.227 9.731
202212 8.428 125.222 8.953
202303 7.621 127.348 7.961
202306 7.128 128.729 7.366
202309 6.506 129.860 6.665
202312 5.908 129.419 6.073
202403 5.176 131.776 5.225
202406 4.597 132.554 4.613
202409 4.049 133.029 4.049

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Lisata Therapeutics  (LTS:0HS8) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Lisata Therapeutics's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=2.72/58.5
=0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Lisata Therapeutics was 1.93. The lowest was 0.01. And the median was 0.07.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Lisata Therapeutics Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Lisata Therapeutics's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Lisata Therapeutics Business Description

Industry
Traded in Other Exchanges
Address
110 Allen Road, 2nd Floor, Basking Ridge, NJ, USA, 07920
Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.

Lisata Therapeutics Headlines

No Headlines